EGFR and cancer: Cytotoxic anticancer drugs inhibit DNA replication [23] or mitosis [24, 25] resulting in apoptosis in several types of cancers including NSCLC [26], while EGFR-TKI inactivates EGFR signalling in NSCLC cells [27].